Green Whistle receives regulatory approval in Singapore
23 September 2015
?Green Whistle receives regulatory approval in Singapore
Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received approval from the Health Sciences Authority of Singapore to market and sell its inhaled analgesic product, ?Penthrox? for trauma and associated pain, as well as pain in surgical procedures in adults.
For more information please click on the following link – ASX Announcement – Approval in Singapore